New study sheds light on how disease progression and biomolecular corona affect nanoparticle-mediated immune activation.

Pharmaceutical scientist aims to foster continued collaborations and drive interdisciplinary research.

Read about the groundbreaking new program that is believed to be the first of its kind in the world in the latest issue of “CATALYST.”

The program has been instrumental in promoting the academic and professional success of students from historically underrepresented backgrounds in the schools of medicine and pharmacy.

Team approach is a win-win for researchers, patients.

James Polli and Lisa Lebovitz received honors at the AACP Annual Meeting in July.

Diverse cohort of scholars represent seven graduate programs.

The School community donated more than $126,000 for student scholarships and financial support.

The School of Pharmacy’s newest dean is ready to take the School into the future.

M-CERSI is a collaboration between the University of Maryland School of Pharmacy and the University of Maryland, College Park.

Cherokee Layson-Wolf is a professor of practice, sciences, and health outcomes research, and James Polli is a professor of pharmaceutical sciences.

Sarah L.J. Michel will lead innovation in the health and life sciences sector.